Search results
...BIOGEN STOCK NOTICE: Lose Money on your Biogen Inc. (Nasdaq: BIIB) Investment? BFA Law Encourages...
Morningstar· 3 days agoNEW YORK, June 15, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities ...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
Zacks via Yahoo Finance· 5 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Connectus Wealth LLC Has $469,000 Position in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 6 days agoConnectus Wealth LLC reduced its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 14.2% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,814 ...
Lighthouse Investment Partners LLC Invests $272,000 in Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 6 days agoLighthouse Investment Partners LLC purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) during the 4th quarter, according to the company in its most ...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Bokf Na
ETF DAILY NEWS· 6 days agoBokf Na lessened its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 20.0% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange ...
... Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit...
Morningstar· 3 days agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) and certain officers. The class action, filed ...
DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...
Morningstar· 4 days agoThe Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines ...
FDA Advisers Like Lilly’s Alzheimer’s Drug. It’s Good News for Biogen.
Barrons.com· 7 days ago“Leqembi has had a lackluster launch thus far due to various administrative challenges and hurdles,”...
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
Morningstar· 7 days agoLOS ANGELES, June 11, 2024 /PRNewswire/ -- , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. ("Biogen" or "the Company") (NASDAQ ...
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab
Zacks via Yahoo Finance· 6 days agoIf Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by...
